The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here are three value stocks with poor fundamentals and some alternatives you should consider instead.
Angi (ANGI)
Forward EV/EBITDA Ratio: 3.8x
Created by IAC’s mergers of Angie’s List and HomeAdvisor, ANGI (NASDAQ: ANGI) operates the largest online marketplace for home services in the US.
Why Does ANGI Worry Us?
- Intense competition is diverting traffic from its platform as its service requests fell by 20.6% annually
- Sales are projected to be flat over the next 12 months and imply weak demand
- Highly competitive market means it’s on the never-ending treadmill of sales and marketing spend
At $12.97 per share, Angi trades at 3.8x forward EV/EBITDA. Check out our free in-depth research report to learn more about why ANGI doesn’t pass our bar.
Organon (OGN)
Forward P/E Ratio: 1.9x
Spun off from Merck in 2021 to create a company dedicated to addressing unmet needs in women's health, Organon (NYSE: OGN) is a global healthcare company focused on improving women's health through prescription therapies, medical devices, biosimilars, and established medicines.
Why Are We Cautious About OGN?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 1.7% annually over the last five years
- Performance over the past five years shows each sale was less profitable as its earnings per share dropped by 17.6% annually, worse than its revenue
- Free cash flow margin dropped by 24.8 percentage points over the last five years, implying the company became more capital intensive as competition picked up
Organon is trading at $7.15 per share, or 1.9x forward P/E. Dive into our free research report to see why there are better opportunities than OGN.
Iridium (IRDM)
Forward P/E Ratio: 14.2x
With a constellation of 66 low-earth orbit satellites providing coverage to every inch of the planet, Iridium Communications (NASDAQ: IRDM) operates a global satellite network that provides voice and data services to customers in remote areas where traditional telecommunications are unavailable.
Why Are We Hesitant About IRDM?
- Estimated sales growth of 2.3% for the next 12 months implies demand will slow from its two-year trend
- Free cash flow margin dropped by 4.8 percentage points over the last five years, implying the company became more capital intensive as competition picked up
- ROIC of 5.2% reflects management’s challenges in identifying attractive investment opportunities
Iridium’s stock price of $17.55 implies a valuation ratio of 14.2x forward P/E. Read our free research report to see why you should think twice about including IRDM in your portfolio.
High-Quality Stocks for All Market Conditions
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
